MicroStrategy
MSTR
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
Meritage Homes
MTH
US Stock MarketDetailed Quotes
AVIR Atea Pharmaceuticals
- 3.190
- +0.060+1.92%
Close Dec 20 16:00 ET
- 3.190
- 0.0000.00%
Post 16:13 ET
269.44MMarket Cap-1.54P/E (TTM)
3.315High3.110Low1.24MVolume3.120Open3.130Pre Close3.98MTurnover1.92%Turnover RatioLossP/E (Static)84.46MShares4.60052wk High0.59P/B206.29MFloat Cap2.75052wk Low--Dividend TTM64.67MShs Float94.174Historical High--Div YieldTTM6.55%Amplitude2.750Historical Low3.205Avg Price1Lot Size
Atea Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -30.95%-23.04M | -161.80%-42.2M | -33.55%-39.87M | 29.42%-85.4M | -1.34%-21.83M | 17.19%-17.59M | 15.98%-16.12M | 49.41%-29.85M | -39.05%-120.98M | 71.43%-21.55M |
| Net income from continuing operations | 6.01%-31.15M | -43.78%-40.52M | -78.11%-63.17M | -17.30%-135.96M | -13.75%-39.16M | -310.89%-33.14M | 10.06%-28.18M | 15.71%-35.47M | -195.64%-115.91M | -129.40%-34.43M |
| Depreciation and amortization | 0.00%104K | 0.00%104K | 0.00%104K | 60.00%416K | 0.00%104K | -1.89%104K | 141.86%104K | 1,385.71%104K | 796.55%260K | 1,385.71%104K |
| Change In working capital | -121.08%-1.56M | -447.56%-11.48M | 458.37%14.1M | 134.69%16.16M | 127.56%9.41M | 133.07%7.38M | 1,443.46%3.3M | 86.25%-3.94M | 81.20%-46.59M | 102.03%4.14M |
| -Change in prepaid assets | -98.64%62K | 461.72%3.12M | 119.65%5.08M | 129.82%1.86M | -135.37%-4.16M | 161.19%4.57M | -131.74%-862K | 740.36%2.31M | -1,194.20%-6.25M | 62.74%-1.77M |
| -Change in payables and accrued expense | -145.24%-1.29M | -472.35%-14.56M | 250.97%9.07M | 136.26%14.36M | 366.39%13.61M | 127.66%2.85M | 216.97%3.91M | 79.20%-6.01M | -173.12%-39.61M | 141.36%2.92M |
| -Change in other current assets | ---287K | --0 | --0 | 106.56%98K | --0 | --0 | --295K | ---197K | -827.95%-1.49M | -2,363.64%-1.49M |
| -Change in other current liabilities | -7.50%-43K | -10.26%-43K | -7.32%-44K | -121.05%-161K | -17.14%-41K | 0.00%-40K | -104.64%-39K | ---41K | --765K | ---35K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -30.95%-23.04M | -161.80%-42.2M | -33.55%-39.87M | 29.42%-85.4M | -1.34%-21.83M | 17.19%-17.59M | 15.98%-16.12M | 49.41%-29.85M | -39.05%-120.98M | 71.43%-21.55M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -108.52%-122.01M | 167.77%124.69M | 132.03%56.8M | 108.85%40.3M | -17.07%27.77M | 87.98%-58.51M | 2,578.18%46.57M | 55,736.36%24.48M | -11,385,150.00%-455.41M | 837,300.00%33.49M |
| Net PPE purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -48,475.00%-1.94M | --0 |
| Net investment purchase and sale | -108.52%-122.01M | 167.77%124.69M | 132.03%56.8M | 108.89%40.3M | -17.07%27.77M | 87.98%-58.51M | --46.57M | --24.48M | ---453.47M | --33.49M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -108.52%-122.01M | 167.77%124.69M | 132.03%56.8M | 108.85%40.3M | -17.07%27.77M | 87.98%-58.51M | 2,578.18%46.57M | 55,736.36%24.48M | -11,385,150.00%-455.41M | 837,300.00%33.49M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 27.17%117K | 0 | -9.09%150K | -30.54%257K | 0 | -37.41%92K | 0 | -26.01%165K | -74.74%370K | 0 |
| Proceeds from stock option exercised by employees | 27.17%117K | --0 | -9.09%150K | -30.54%257K | --0 | -37.41%92K | --0 | -26.01%165K | --370K | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 27.17%117K | --0 | -9.09%150K | -30.54%257K | --0 | -37.41%92K | --0 | -26.01%165K | -74.74%370K | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | 13.79%243.39M | -12.29%160.91M | -23.77%143.82M | -75.33%188.66M | -21.97%137.89M | -68.76%213.9M | -74.01%183.45M | -75.33%188.66M | -10.06%764.68M | -78.96%176.72M |
| Current changes in cash | -90.67%-144.93M | 170.93%82.48M | 428.28%17.09M | 92.22%-44.84M | -50.29%5.94M | 85.04%-76.01M | 244.53%30.45M | 91.15%-5.21M | -573.36%-576.02M | 115.86%11.94M |
| End cash Position | -28.59%98.46M | 13.79%243.39M | -12.29%160.91M | -23.77%143.82M | -23.77%143.82M | -21.97%137.89M | -68.76%213.9M | -74.01%183.45M | -75.33%188.66M | -75.33%188.66M |
| Free cash flow | -30.95%-23.04M | -161.80%-42.2M | -33.55%-39.87M | 30.53%-85.4M | -1.34%-21.83M | 17.27%-17.59M | 23.47%-16.12M | 49.45%-29.85M | -41.28%-122.93M | 71.44%-21.55M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.